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Refugio Robles-Sikisaka1, Mayuri Naidu1, Melissa Ly1, Julia Salzman2, Shira R Abeles3, Tobias K Boehm4
and David T Pride1,3*Abstract
Background: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) are utilized by bacteria to resist
encounters with their viruses. Human body surfaces have numerous bacteria that harbor CRISPRs, and their content
can provide clues as to the types and features of viruses they may have encountered.
Results: We investigated the conservation of CRISPR content from streptococci on skin and saliva of human
subjects over 8-weeks to determine whether similarities existed in the CRISPR spacer profiles and whether CRISPR
spacers were a stable component of each biogeographic site. Most of the CRISPR sequences identified were unique,
but a small proportion of spacers from the skin and saliva of each subject matched spacers derived from previously
sequenced loci of S. thermophilus and other streptococci. There were significant proportions of CRISPR spacers
conserved over the entire 8-week study period for all subjects, and salivary CRISPR spacers sampled in the mornings
showed significantly higher levels of conservation than any other time of day. We also found substantial similarities
in the spacer repertoires of the skin and saliva of each subject. Many skin-derived spacers matched salivary viruses,
supporting that bacteria of the skin may encounter viruses with similar sequences to those found in the mouth.
Despite the similarities between skin and salivary spacer repertoires, the variation present was distinct based on
each subject and body site.
Conclusions: The conservation of CRISPR spacers in the saliva and the skin of human subjects over the time period
studied suggests a relative conservation of the bacteria harboring them.
Keywords: CRISPR, Skin microbiome, Saliva microbiome, Virome, VirusBackground
Viruses form a substantial portion of the human micro-
biome, and many have previously been identified as
bacteriophage living in association with the numerous
cellular microbes that inhabit human body surfaces
[1-4]. Relative to their bacterial counterparts, there have
been comparatively few studies characterizing human
viral communities [3-9]. Many of these studies of human
viruses generally have been limited to cross-sectional
analyses, where little could be ascertained about the
stability or the rate of turnover of viruses in these envi-
ronments. Moreover, the effects of environment on the* Correspondence: dpride@ucsd.edu
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article, unless otherwise stated.composition of human viral communities have not been
thoroughly examined. We recently demonstrated that
individuals living together are significantly more likely to
have similar oral viruses [10].
CRISPRs (Clustered Regularly Interspaced Short
Palindromic Repeats) are part of the CRISPR/Cas sys-
tem in bacteria and archaea and mediate an adaptive
immune response against invading viruses. They func-
tion by acquiring short sequences from invading vi-
ruses into the CRISPR locus, and counteract future
infections through nucleic acid interference [11-13]. Be-
cause CRISPR loci acquire and accumulate short viral se-
quences, they have been used to trace viral exposures
[14-18]. In addition to having similar oral viruses, house-
hold members also have significant similarities in their
CRISPR spacer profiles [10], suggesting that oral CRISPR
spacers may evolve as a result of each individual’s oral vir-
ome composition.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and respiratory secretions provide sufficient biomass to
characterize viral populations [1,3,4,19], the skin generally
presents a more challenging body surface on which to
characterize viruses. Because of a general lack of starting
material, analysis of the skin microbiome mostly has been
limited to analysis of those microbes on skin swabs or
scrapings [20-22]. To analyze skin viral populations,
Foulongne et al. recently used high-throughput sequencing
techniques to sequence the skin metagenome, and to
analyze those viruses present by targeted analysis of viral
reads [23]. In most human sample types, the majority of
the viruses present have been identified as bacteriophage
[1-3,19], which may reflect the 10 to 1 proportion of bacter-
ial to human cells in these environments. In analysis of the
skin virome, however, bacteriophage constituted only a
small proportion of the metagenome sequences [23]. By
examining the CRISPR spacer profiles of the skin, we may
improve our understanding of the sequence features of
viruses to which skin bacteria have previously encountered.
Study of the human microbiome has detailed unique
populations of microbes inhabiting different body sur-
faces. While the oral cavity and the skin surfaces differ
substantially in their bacterial constituents, they share
some bacterial genera including some species from the
genus Streptococcus [24]. Streptococci generally are
present on the skin and in the saliva of most humans
[25-28], and represent a substantial proportion of the
oral microbiota and a much smaller proportion of the
skin microbiota [29-33]. The human oral cavity is known
to harbor various types of viridans streptococci, including
S. mutans, S. gordonii, S. oralis, S. mitis, S. milleri (includes
S. anginosus, S. constellatus, and S. intermedius), S. sangui-
nis, and S. parasanguinis, and also some non-viridans
streptococci, including S. bovis (includes S. gallolyticus, S.
equinus, and S. infantarius, among others). The skin gener-
ally harbors different species of streptococci, including S.
pyogenes and S. agalactiae, which belong to Lancefield
groups A and B, respectively. The skin also is known to
harbor streptococci that belong to Lancefield groups C and
G [24]. In this study, we sought to characterize the CRISPR
profiles present in a cohort of human subjects on both their
skin and in their oral cavities. Our goals were to determine
whether there were similar CRISPR profiles among strepto-
cocci on human skin and saliva, whether CRISPR content
on the skin and saliva was relatively conserved over time,
and whether there were CRISPR spacers present on human
skin that matched viruses present in saliva.
Results
CRISPR spacer sequencing
We sampled 4 human subjects with good overall cutaneous
and periodontal health, collecting skin swabs and saliva
samples 3 times per day on days #1, #2, #4, #14, #28, andweek #8. Skin and saliva samples were collected at the same
time in the AM prior to breakfast or oral hygiene (AM), ap-
proximately noon each day before lunch (Noon), and in the
early evening prior to dinner [34]. Skin samples were col-
lected from the volar surface of the forearm, as prior studies
utilizing this surface provide insight into its indigenous
microbes [31,33,35]. We analyzed Streptococcus Group I
(SGI) and Streptococcus Group II (SGII) CRISPRs, by
amplifying them based on their consensus repeat motifs
(Additional file 1: Table S1) [14,15]. These CRISPR repeat
motifs are present in a variety of different streptococcal spe-
cies, including S. pyogenes and S. agalactiae that are pri-
marily found on the skin, and numerous different viridans
streptococci such as S. mutans, S. gordonii, S. mitis, and S.
sanguinis that are found in the oral cavity (Additional file 1:
Table S2). The benefits of this approach were that we could
analyze CRISPR spacers from numerous streptococcal spe-
cies simultaneously and were not limited to examining indi-
vidual CRISPR loci. The main drawbacks of this technique
were that it was difficult to ascribe the spacers to any single
CRISPR locus or bacterial species, and the consensus repeat
motifs could be present in some non-streptococcal species.
We amplified CRISPRs from all subjects, sample types, and
time points, and sequenced 4,090,937 CRISPR spacers con-
sisting of 2,212,912 SGI and 1,878,025 SGII spacers using
semiconductor sequencing [36] (Additional file 1: Table
S3). There were 2,169,768 spacers obtained from saliva and
1,921,169 spacers obtained from skin. For all time points
combined, we found 1,055,321 spacers for Subject #1,
781,534 spacers for Subject #2, 1,088,339 for Subject #3,
and 891,618 spacers for Subject #4.
Spacer binning and estimated coverage
We binned each of the CRISPR spacers according to tri-
nucleotide content according to our previously described
protocols [10]. The majority of the CRISPR spacers iden-
tified in each subject and time point were identical to
other spacers, with only 0.001% of SGI and 0.002% of
SGII spacers identified as having polymorphisms that
necessitated grouping according to trinucleotide content.
We sequenced an average of 28,333 spacers per time
point and sample type in each subject to capture the ma-
jority of the CRISPR spacer diversity in these environ-
ments. We then performed rarefaction analysis on all
subjects by CRISPR and sample type to estimate how
thoroughly each had been evaluated. We found that all
curves neared asymptote for all subjects, sample types,
and time points, with the exception of Subject#1 in the
evening of week 8 for SGII CRISPR spacers (Additional
file 2: Figure S1).
CRISPR spacer distribution
We compared CRISPR spacers and their relative abun-
dances across all time points in each subject to determine
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each time point, many of the spacers found at early time
points persisted throughout later time points (Figure 1 and
Additional file 2: Figure S2), indicating that many of the
SGI and SGII CRISPR spacers were conserved throughout
the study period. We quantified the proportions of persist-
ent SGI salivary spacers and found 61% to be persistent in
Subject #1, 62% in Subject #2, 36% in Subject #3, and 49%
in Subject #4 (Figure 2 and Additional file 1: Table S4). This
was similar for SGII salivary spacers (45% persistent in Sub-
ject #1, 65% in Subject #2, 51% in Subject #3, and 58% in
Subject #4) (Additional file 2: Figure S3 and Additional file
1: Table S4). There was a smaller yet similar group of
spacers on the skin of each subject for SGI spacers (38% in
Subject #1, 36% in Subject #2, 15% in Subject #3, and 24%
in Subject #4) and SGII spacers (39% in Subject #1, 28% in
Subject #2, 10% in Subject #3, and 36% in Subject #4)
persisting throughout the study. Many of the conserved
spacers in saliva matched spacers on the skin of eachFigure 1 Heatmaps of SGI CRISPR spacer groups in all subjects. Each
individual time point. Each day is listed, where M represents morning, N re
spacer groups are demonstrated on the left, and skin-derived CRISPR space
located to the right, and represents the percentage of total spacers found at ea
Panel C – Subject #3, and Panel D – Subject #4.subject for SGI spacers (44% in Subject #1, 41% in
Subject #2, 11% in Subject #3, and 25% in Subject #4)
and SGII spacers (42% in Subject #1, 30% in Subject #2,
17% in Subject #3, and 37% in Subject #4).
We measured the relative conservation of SGII and
SGI spacers by time of day sampled to determine
whether there were biases in CRISPR spacer profiles on
the skin and in the saliva based on sampling times. We
found that in the saliva, there was significantly greater
conservation (p < 0.05) of CRISPR spacer profiles in the
AM for both SGII (Figure 3, Panel A) and SGI spacers
(Panel B). Similar conservation of CRISPR spacer pro-
files were not found for Noon and PM time points for
either SGII or SGI spacers in saliva (Additional file 2:
Figures S4 and S5). Because the saliva samples were col-
lected prior to meals and oral hygiene practices in the
AM, while the Noon sample was collected after break-
fast and oral hygiene and the PM time point was col-
lected after lunch, we believe that the substantial timerow represents a unique spacer group and the columns represent each
presents noon, and E represents evening. Saliva-derived SGI CRISPR
r groups are on the right of each panel. The intensity scale bar is
ch time point in each subject. Panel A – Subject #1, Panel B – Subject #2,
Figure 2 SGI CRISPR spacer group heat matrices from all subjects. Each matrix demonstrates the percentage of shared SGI CRISPR spacer
groups between all time points within each subject. The top triangular portion of each matrix represents comparisons between saliva-derived
CRISPR spacers, the bottom rectangular portion of each matrix represents comparisons between saliva-derived and skin-derived CRISPR spacers,
and the bottom triangular portion of each matrix represents comparisons between skin-derived CRISPR spacers. The intensity scale bar is located
to the right of each matrix. Panel A – Subject #1, Panel B – Subject #2, Panel C – Subject #3, and Panel D – Subject #4.
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greater stability of the oral bacteria harboring these
CRISPR loci. Similar results were not found on the skin
for any time points (Figure 3, Panels B and C, and
Additional file 2: Figures S4 and S5). We did not con-
trol for skin-related hygiene practices, which may have
affected the skin microbiota.
When compared to skin spacers, the proportion of
shared spacers in saliva over time in each subject was
highly significant (p < 0.005 in all subjects for SGII and
SGI spacers) (Additional file 1: Table S4). In some cases
there were more shared spacers between skin and saliva
than there were for comparisons of different time points
within the skin of the same subject for SGII spacers
(44% shared between saliva and skin versus 37% shared
in skin for Subject #1; 41% vs 36% in Subject #2; 11% vs
15% for Subject #3; 25% vs 24% for Subject #4) and for SGI
spacers (42% shared between saliva and skin versus 39%
shared in skin for Subject #1; 30% vs 28% in Subject #2;
16% vs 10% for Subject #3; 37% vs 36% for Subject #4).
These data demonstrate a smaller group of shared
spacers present on the skin of these subjects than in
their saliva, which suggests greater heterogeneity in
the skin microbiota.
We also examined spacers shared between different
subjects and whether there were any SGI CRISPR
spacers shared with SGII spacers. On average, 21.86 ±
1.98% of the SGI spacers were shared between subjects,
20.93 ± 2.34% of the SGII spacers were shared betweensubjects, while only 0.011 ± 0.004% (p < 0.001) of the SGI
and SGII spacers were shared between subjects, indicat-
ing that either SGI and SGII spacers likely target differ-
ent viruses/plasmids, or target different portions of the
same viruses/plasmids [37].
CRISPR locus assembly
Because of the short read lengths of most of the se-
quences produced in this study, CRISPR loci could not
be assembled; however, longer reads sequenced from the
day 14 AM sample from subject #3 could be assembled
into loci. By using adjacent spacers as scaffolds, we were
able to reconstruct 8 different CRISPR loci in the saliva
and 28 different CRISPR loci on the skin. Of the 8 loci
reconstructed in the saliva, 4 shared at least 1 spacer
with loci reproduced on the skin (Figure 4). We identi-
fied CRISPR loci that were identical between the skin
and saliva (Panel A), that shared a common end (Panel B),
that shared a common middle (Panel C), and that only
shared a single spacer flanked by spacers not present at the
other body site (Panel D). Only a single spacer from any of
these 4 loci is identical to any previously sequenced spacers.
These data suggest that at least some of the shared spacers
on the saliva and skin were derived from loci with shared
spacer content and order.
Analysis of CRISPR spacer variation
Because there were shared spacers between the saliva
and skin of each subject (Figure 2 and Additional file 2:
Figure 3 Conservation of CRISPR spacer content by time of day sampled. Each panel demonstrates the relative conservation of spacers
(±standard deviation) within the morning time points for each subject (M vs. M), comparisons of the morning time points with noon time points
(M vs. N), and comparisons of the morning time points with the evening time points (M vs E) for subject #1 (magenta), subject #2 [22], subject #3
(red), and subject #4 (cyan). Panels A and B represent salivary SGII and SGI CRISPR spacers, respectively. Panels C and D represent skin-derived
SGII and SGI CRISPR spacers, respectively. The '*' represents subjects in which the relative conservation of spacers for the morning time points is
significantly (p≤ 0.05) greater than for comparisons of morning and noon/evening time points.
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the spacers in the saliva versus the skin was unique
based on environment. Principal coordinates analysis of
the CRISPR spacer repertoires examining only the pres-
ence/absence of spacers demonstrated that at most time
points the biogeographic site was an important deter-
minant of diversity for SGI spacers (Figure 5, panel A)
and SGII spacers (Figure 5, panel B). We also used a
permutation test [10] to determine whether there was a
significant association amongst the spacers by biogeo-
graphic site (skin or saliva). Briefly, we tested whether
the fraction of shared spacers amongst the skin spacers
or amongst the salivary spacers would be greater than
for comparisons of spacers on the skin against spacers in
saliva. We performed this test by randomly sampling
1,000 spacers from each subject over 10,000 iterations.
We found that the estimated fraction of shared spacers
over time amongst the salivary spacers was highly sig-
nificant (p < 0.0001 for each) (Table 1). The estimated
fraction of shared spacers amongst the skin spacers of
each subject was no greater than for comparisons of skin
against saliva, with no significant relationships found.These data indicate that there is a highly significant group
of shared SGI and SGII CRISPR spacers present in saliva
that is not paralleled on the skin of each subject.
We also examined CRISPR repertoires by collapsing
all time points between subjects to determine whether
the CRISPR spacers in each environment were a direct
reflection of the subject and environment from which
they were derived. When considering both the presence
of spacers and their abundance in skin and saliva, we
found that for most subjects the CRISPR repertoires
were significantly subject-specific (Additional file 1: Table
S5). We estimated that 94% of the SGII spacers were
conserved across the skin and saliva of Subject #1 com-
pared to only 35% when comparing between different sub-
jects (p < 0.0001). Similar results were produced for all
subjects for both SGI and SGII CRISPR spacers with the
exception of Subject #4 (Additional file 1: Table S5). While
the results did not reach statistical significance for Sub-
ject#4, the trends in the proportions of intra-subject shared
spacers between skin and saliva exceeded inter-subject
comparisons substantially (86% vs 57% for SGI spacers and
58% vs 35% for SGII spacers).
Figure 4 Assembled CRISPR loci from subject #3 on day 14 in
the morning. Panels A-D represent different loci that were
reconstructed, and shared CRISPR spacers between the loci of the
skin and saliva are noted by colored boxes. White boxes represent
spacers that were unique to either the skin or saliva. Numbers in the
boxes represent the unique identifiers given to each spacer.
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We tested whether the spacer repertoires from skin and
saliva matched similar viruses (Additional file 2: Figure
S6). We found that 8.6% of saliva-derived and 25.3%
of skin-derived SGII spacers were homologous to
streptococcal viruses in the NCBI Non-redundant (NR)
database, and 6.9% of saliva-derived and 15.3% of skin-
derived SGI spacers were homologous to streptococcal
viruses. Comparatively, only 4.5% of saliva-derived and
6.5% of skin-derived SGII spacers were homologous to
streptococcal plasmids, and 0.3% of saliva-derived and
0.9% of skin-derived SGI spacers were homologous to
streptococcal plasmids. In all cases, the proportion of
skin-derived spacers with homologues in the NR data-
base was significantly (p ≤ 0.005) greater than that for
saliva-derived spacers. We created heatmaps of the spa-
cer homologues across all time points for both saliva
and skin, where only spacers that were newly identified
at each time point were included. For many of the viral
homologues, newly identified spacers targeted different
portions of the same viruses over time for both SGI
spacers (Figure 6, panel A) and SGII spacers (Figure 6,
panel B), suggesting that the bacteria harboring these
CRISPR spacers either acquired additional resistance
motifs against the same or similar viruses or that new
bacterial strains harboring spacers targeting these viruses
entered the community. Most of the viruses that
matched CRISPR spacers in this study were previouslyidentified in S. thermophilus and S. pneumoniae. We also
noted that 38.7 ± 0.09% of the SGII and 40.4 ± 0.11% of
the SGI spacers on the skin matched the same viruses as
those spacers identified in saliva. Approximately 53.3 ±
1.2% of the SGII and 40.4 ± 3.2% of the SGI CRISPR
spacers from different subjects matched the same vi-
ruses. A few of the spacers matched viruses found in
species of Lactococcus, which are closely related to
Streptococcus.
We also compared the CRISPR spacers from the skin
and saliva of all subjects to determine whether there
might be spacers in our cohort that matched those iden-
tified in previously sequenced CRISPR loci. We found
that 2-8% of the CRISPR spacers were also found in loci
from the CRISPR database [38], with the number of skin
spacers found in the database generally exceeding saliv-
ary spacers (Figure 7, Panel A). While there were spacers
identified that matched loci from many different strepto-
coccal species, the majority of the loci belonged to S.
thermophilus. For example, many of the SGII 3’ spacers
from CRISPR Locus 1 of S. thermophilus LMG18311 were
identified on the skin of subject #1, but only 1 of those
spacers was identified in the saliva (Figure 7, Panel B1).
All of the SGII spacers in Locus 1 of S. thermophilus
MN-ZLW-002 were identified on the skin of subject #2,
but 1 was missing in the saliva of that subject (Panel
B2). Similar patterns of shared spacers were found in
subjects #3 and #4 (Panels B3-B4). SGI spacers also
matched spacers from various S. thermophilus loci
(Panels C1-C4). These data suggest that loci similar to
those isolated from S. thermophilus were sampled on
both the skin and saliva of our study subjects.
To determine whether skin-derived CRISPR spacers
matched viruses present in the saliva, we sequenced the
viromes present in each of our subjects’ saliva on Day 1
and Week 8. Similar to our previous studies [14], the
proportion of CRISPR spacers matching virome reads
was relatively low. When examining the pooled reads
from all subjects, we found that between 0.0% and 1.0%
of the CRISPR spacers in each subject matched virome
reads for SGI spacers and SGII spacers (Additional file
2: Figure S7). When we tested the skin- and saliva-
derived spacers against a larger database of salivary vir-
omes from a cohort 21 human subjects [10], we found
that a high number of salivary- and skin-derived spacers
matched salivary virome reads (range from 14 to 60% for
SGII spacers and 10 to 24% for SGI spacers). The pro-
portion of spacers matching salivary viruses was signifi-
cantly (p ≤ 0.002) higher for saliva-derived spacers than
for skin-derived spacers for Subjects #3 and #4 for SGII
spacers, but not Subjects #1 and #2. There also were a
significantly higher proportion of SGI saliva-derived
spacers that matched salivary viruses in Subjects #2
and #3, but not Subjects #1 and #4 (Figure 8).
Figure 5 Principal coordinates analysis of CRISPR spacer groups between skin and saliva. Beta diversity was determined using Sorensen’s
distances. Panel A represents SGI CRISPR spacers and Panel B represents SGII CRISPR spacers. Subpanel 1 represents Subject#1, Subpanel 2
represents Subject #2, Subpanel 3 represents Subject #3, and Subpanel 4 represents Subject #4. Salivary CRISPRs are represented in black,
and skin CRISPRs are represented in gray.
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found in previously sequences metagenomes recovered
from the human oral cavity [39], the gastrointestinal
tract [40], and human skin [41]. We found that a signifi-
cantly higher percentage of SGII (3-4%) and SGI (4-5%)
spacer sequences were found in oral metagenomes than
the 1-2% of SGII and SGI found in the gut and the <1%
found on the skin (p < 0.02) (Additional file 2: Figure S8,
Panels A and B). While the significant difference be-
tween spacers shared between oral and gut metagen-
omes is consistent with a prior study [14], the lack of
spacers found on skin metagenomes may be secondary
to the different surfaces sampled between studies, where
the retroauricular surface was sampled to produce the
skin metagenomes compared to the volar forearm sur-
face used in this study.Table 1 Estimated shared CRISPR spacers in saliva and skin
Saliva
Subject Percent shareda p-valueb
SGI
Subject 1 45.91 ± 1.56 <0.0001
Subject 2 55.64 ± 1.51 <0.0001
Subject 3 23.86 ± 1.37 <0.0001
Subject 4 38.60 ± 1.53 <0.0001
SGII
Subject 1 48.13 ± 1.61 <0.0001
Subject 2 50.75 ± 1.55 <0.0001
Subject 3 35.31 ± 1.51 <0.0001
Subject 4 52.52 ± 1.57 <0.0001
aBased on the mean of 10,000 iterations. 1,000 random spacers were sampled per i
bEmpirical p-value based on the fraction of times the estimated percent shared spa
p-values ≤0.05 are represented in bold.Spacer rate change
Little is known about the rate at which spacers are ac-
quired for bacteria in human ecosystems. Due to our re-
peat motif based amplification approach, we were
unable to discern between newly acquired spacers in
existing bacteria and those that may be newly identified
because of new bacteria entering the environment. We
could, however, compare the estimated rates of newly
identified spacers between skin and saliva. To estimate
the number of spacers at each time point, we corrected
for the probability that any spacer present at a given
time point might not be observed due to variations in
sampling. For SGII spacers the estimated rate of newly
identified spacers per hour for skin exceeded that for sal-
iva in all subjects, and was significant (p < 0.05) for 3 of
the 4 subjects (Additional file 2: Figure S9, Panel A).Skin Saliva vs skin
Percent shareda p-valueb Percent shareda
23.97 ± 1.36 0.9945 29.39 ± 1.51
27.31 ± 1.41 0.9849 31.78 ± 1.44
10.27 ± 0.97 0.1584 8.99 ± 0.89
16.05 ± 1.19 0.6741 16.83 ± 1.17
28.50 ± 1.40 0.9947 34.07 ± 1.56
21.64 ± 1.31 0.2537 20.50 ± 1.25
7.64 ± 0.84 0.9827 10.37 ± 0.99
25.78 ± 1.39 0.9439 28.95 ± 1.41
teration.
cers for comparisons within skin or saliva exceeds that between skin and saliva.
Figure 6 Heatmaps of CRISPR spacers homologous to bacteriophage in the NCBI Non-redundant database. Each row represents a unique
phage and the columns represent spacers from all individual time points (from left to right) in all subjects. For each column, homologues are
only shown for CRISPR spacer groups that were not present at any prior time points in each subject. The subject and sample type are denoted at
the top of each heatmap, and the organisms from which the phage were isolated are located on the left. The intensity scale bar is located to the
right. Panel A – SGII CRISPR spacers and Panel B – SGI CRISPR spacers.
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(Additional file 2: Figure S9, Panel B), where only in
subject #2 did the estimated rate for skin significantly
exceed saliva. The overall rate per hour of newly iden-
tified SGII spacers was significantly higher for skin
(15.8 ± 1.7) than for saliva (7.6 ± 1.2; p < 0.001), while it
was similar for skin (16.9 ± 1.8) and saliva (16.3 ± 2.6;
p = 0.422) for SGI spacers.
Bacterial community variation
Because many of the SGI and SGII CRISPR spacers were
subject specific and shared between skin and saliva, we
also characterized the bacterial communities in each
subject to ensure that the microbiota of each body site
were distinct. We sequenced a total of 2,020,553 readsfrom the V3 region of 16S rRNA, for an average of
21,047 reads per time point and sample type for all sub-
jects over the 8-week study period. We performed prin-
cipal coordinates analysis for the bacterial communities
to determine whether the variation in these communities
may be subject specific and reflective of the body site
from which they were derived, as had been demon-
strated for SGI and SGII CRISPRs (Figure 5). The major-
ity of the variation observed between skin and saliva was
on the x-axis, which accounted for 66% of the observed
variation (Additional file 2: Figure S10). The bacterial
communities from both saliva and skin appeared to be
highly specific to the body site examined, but not subject
specific. We quantified the proportion of shared OTUs
(Operational Taxonomic Units) within and between the
Figure 7 Percentage of CRISPR spacers (±standard deviation) that match spacers from previously identified CRISPR loci in the CRISPR
Database (Panel A), and profiles of the spacer matches to specific CRISPR loci from different strains of S. thermophilus for SGII (Panel
B) and SGI (Panel C) spacers. In panels B and C, each box represents a spacer in a CRISPR locus in the CRISPR Database, and colored boxes
represent spacers that also were present in this study. White boxes represent spacers that were not identified in this study. In each subpanel, the
colored boxes from the top locus represent spacers that were matched by skin-derived spacers, and the bottom box represents spacers that were
matched by saliva-derived spacers.
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a significant proportion conserved in the saliva of each
subject (p ≤ 0.05; Additional file 1: Table S6). While only
Subjects #1, #3, and #4 had significant proportions of
shared OTUs (p ≤ 0.05) on the skin, the proportion
shared on the skin of Subject #2 substantially exceededFigure 8 Percentage of SGI (Panel A) and SGII (Panel B) CRISPR space
[10]. The Y-axis shows the mean percentage of the CRISPR spacers from al
21 subjects. The X-axis represents the saliva- and skin-derived spacers for e
the p-value is demonstrated above each error bar. Subjects 1 through 4 arethose shared between the saliva and skin (62% vs. 36%;
p = 0.24). There also was a greater abundance of strepto-
cocci in the saliva than on the skin of each subject
(mean 29.8 ± 2.2% vs 5.8 ± 1.3%; p < 0.001) (Additional
file 2: Figure S11, Panels A and B). These data indicate
that while there were discernible differences between thers matching virome reads from the saliva of 21 human subjects
l time points combined that matched virome reads from the cohort of
ach subject. Standard error bars are represented above each bar, and
shown consecutively from left to right on the X-axis.
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skin and saliva for each subject, only the CRISPR spacer
profiles were subject specific.
Discussion
The study of viruses inhabiting body surfaces is still in
its relative infancy. Because little biomass can be ob-
tained non-invasively from the skin, viral communities
on this surface remain relatively poorly characterized.
Others have begun to characterize some of the features
of the viruses in this broad ecosystem [23], yet their ana-
lysis has not identify many viruses of bacteria. Because
of the abundance of bacteria inhabiting human skin, the
skin might be expected to be inhabited by many bac-
teriophage, as has previously been demonstrated for the
human oral cavity [1,2] and gut [4,7]. We sampled
CRISPRs because their profiles may shed light into the
diverse features and types of viruses to which strepto-
cocci on the skin might encounter in nature, and might
be contrasted with viruses found in saliva. While we
found many spacers on skin that matched those of sal-
iva, many may belong to loci that have been either verti-
cally or horizontally inherited; thus, the similarities
between skin and salivary CRISPR spacer profiles may
not reflect independent viral encounters. It does repre-
sent an intriguing possibility that bacteria on the skin
and saliva encounter similar viruses, but this study was
not designed to demonstrate that phenomenon.
While there were relatively few CRISPR spacers that
matched salivary viruses from the subjects in this study,
there were many that matched viruses from a larger co-
hort of different subjects [10]. We previously demon-
strated that CRISPR spacer/virome matches generally
are not subject specific [14], and we believe that this
phenomenon may be due to heterogenous representa-
tion of viruses between different subjects. For example,
similar viruses may be present in both subjects, but in
one subject one virus may be highly abundant at the
time of sampling, while in another subject it is not.
Therefore, by comparing CRISPR spacers to viromes
from multiple subjects, we may identify matches to vi-
ruses that are of otherwise too low an abundance to be
identified in our cohort.
The repeat-based amplification technique used in this
study was not without limitations, including that we
could not ascribe most spacers to bacterial species or
CRISPR loci [15]. Additionally, CRISPR spacers could
have been amplified from loci that are similar but not
identical to SGII and SGI CRISPR repeat motifs [42]. By
removing any altered CRISPR repeat motifs from the
analysis, we also could limit the potential effect of ampli-
fying non-streptococcal species that might bear similar
repeat motifs. We believe that much of the similarity ob-
served in our analysis of SGI and SGII CRISPRs betweenthe skin and saliva was due to the presence of different
streptococcal species harboring these repeat motifs on both
body sites, as the vast majority of homologous sequences
found to our CRISPR spacers were from streptococcal
phage, plasmids, and genomes. We attempted to find and
include spacer sequences from CRISPR repeat motifs not
known to be present in Streptococcus, including repeat mo-
tifs found in species of Gemella, Veillonella, Leptotrichia,
and Kingella, but their presence was not uniform on the
skin (data not shown).
Because of the error rate of Ion Torrent sequencing
[36], we took additional precautions to reduce sequen-
cing error biases in our analysis of CRISPR spacers. Each
CRISPR-bearing read was trimmed according to quality
scores, and was removed if it had significant homopoly-
mer tracts. We specifically removed any CRISPR-bearing
reads from the analysis that did not match the known
consensus repeat motifs, as those reads were more likely
to contain sequencing errors. The combination of these
techniques reduced the error rate from approximately
1% to an estimated 0.001 and 0.002% for SGI and SGII
CRISPR spacers, respectively. Our previous studies of
CRISPR repertoires in humans had been performed
using conventional Sanger sequencing, however we now
have extended our analysis using next-generation se-
quencing techniques. The primary benefit of the current
technique was that we were able to achieve greater sam-
pling depth, which allowed for more robust comparisons
of skin and salivary CRISPRs with fewer unsampled
spacers.
Our data on shared CRISPR spacers between skin
and saliva revealed several qualities about CRISPRs on
human body surfaces: 1) fewer spacers were shared
between subjects than within subjects, suggesting that
CRISPR repertoires were individual specific, 2) the sub-
stantial persistence of spacers, suggesting that the bac-
teria harboring them were conserved over the time
period studied, and 3) the level of shared spacers be-
tween skin and saliva in individual subjects (Figure 1
and Additional file 2: Figure S2), which raises the possi-
bility that skin-derived bacteria may have encountered
viruses with similar sequences to those in the mouth.
While it is possible that some of the spacers were
acquired through independent means [10], the sub-
stantial levels of shared spacers between skin and
saliva suggests some vertical or horizontal acquisitions.
Despite our inability to reconstruct many CRISPR loci
using this short-read technology, our finding that many
spacers from previously sequenced S. thermophilus iso-
lates were present in this cohort suggests that those
loci may be present in this study with their spacer con-
tent and order intact. Because the location of the
CRISPR loci in our subjects was variable, we were un-
able investigate them robustly by PCR amplification
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sequencing.
We initially hypothesized that there would be large
groups of spacers specific to saliva and specific to skin
that would be unique to each body surface. We found
that there was a group of salivary spacers that were
highly persistent over the 8-week study period, but the
same trend was not true for skin spacers (Table 1). We
believe that the lower level of spacer persistence on skin
may be secondary to increased heterogeneity in skin
bacterial populations over time. We analyzed the bacter-
ial populations using 16S rRNA specifically to substanti-
ate that there were differences between skin and salivary
microbiota in these subjects, as the substantial levels of
shared CRISPR spacers between the body sites in such
a large dataset were unexpected. The segment of 16S
rRNA sequenced was not sufficient to differentiate dif-
ferent streptococci at the species level, but was sufficient
to discern differences between the microbiota of each
body site.
Conclusions
We aimed to characterize streptococcal CRISPR spacer
profiles of distinct human biogeographic sites to deter-
mine whether CRISPR spacers were highly conserved
over time. We found that there were robust repertoires
of spacers from both sites, but neither profiles were fully
ecologically distinct. There were abundant shared spacers
between the skin and saliva of all 4 subjects (Figure 1), sug-
gesting vertical or horizontal acquisition of CRISPR loci
among the streptococci inhabiting these body sites. The sig-
nificant group of temporally conserved spacers in saliva
was much larger than that found on skin (Table 1), which
might reflect a higher diversity of cutaneous bacterial
strains. While many of the CRISPR spacers identified in sal-
iva matched concurrent viruses in saliva, the relatively high
proportion of skin-derived spacers matching salivary viruses
warrants further study to determine whether streptococci
on the skin may encounter viruses with similar sequences
to those in the mouth.
Methods
Human subjects
This full study including the enrollment of human sub-
jects and the consent procedure was approved by the
University of California, San Diego and the Western
University institutional review boards. Each subject do-
nated saliva samples and skin swabs three times daily at
various time points over an 8-week period (Day 1 AM,
Noon, PM; Day 2 AM, Noon, PM; Day 4 AM, Noon,
PM; Day 14 AM, Noon, PM; Day 28 AM, Noon, PM;
Week 8 AM, Noon, PM). Prior to sample collection,
each subject completed a survey self-reporting his or
her oral health and any other pre-existing medicalconditions that could result in substantial immunosup-
pression, and reported themselves to be in good overall
cutaneous and periodontal health. Exclusion criteria also
included antibiotic administration during the 12 months
prior to the beginning of the study. Each subject pro-
vided a minimum of 3 ml of non-stimulated saliva at all
time points, and a skin swab from the volar surface of
their forearm. The same volar surface from the same
arm was used for each subject throughout all time
points sampled. Samples from skin were collected on a
swab soaked in a solution of 0.15 M NaCl and 0.1%
Tween 20 and were resuspended in PBS [31]. Saliva and
skin samples were frozen at −80°C prior to use in this
study. All AM time points were collected prior to meals
or oral hygiene practices, the noon time point was collected
prior to lunch, and the PM time point was collected prior
to dinner. The study was not controlled for cutaneous
hygiene practices.
Amplification and binning of streptococcal CRISPR spacers
From each subject, genomic DNA was prepared from
saliva and skin using Qiagen QIAamp DNA MINI kit
(Qiagen, Valencia, CA). Each sample was subjected to a
bead beating step prior to nucleic acid extraction using
Lysing Matrix-B (MP Bio, Santa Ana, CA). SGI and SGII
CRISPR primers were designed based on their specificity
to the CRISPR repeat motifs present in S. gordonii str.
Challis substr. CH1 and S. mutans UA159, and included
barcode sequences (Additional file 1: Table S1) [14].
Each primer was used to amplify CRISPRs from saliva
and skin-derived DNA by PCR. Reaction conditions in-
cluded 45 μl Platinum High Fidelity Supermix (Life
Technologies, Grand Island, NY), 1 μl of each of the for-
ward and reverse primer (20 pmol each), and 3 μl salivary
or skin-derived DNA template. The cycling parameters
were 3 minutes initial denaturation at 95°C, followed by
30 cycles of denaturation (60 seconds at 95°C), annealing
(60 seconds), and extension (5 minutes at 72°C), followed
by a final extension (10 minutes at 72°C). CRISPR ampli-
cons were gel extracted using the Qiagen MinElute Kit
(Qiagen, Valencia, CA) including buffer QG and further
purified using Ampure beads (Beckman-Coulter, Brea, CA).
Molar equivalents were determined from each product
using an Agilent Bioanalyzer HS DNA Kit (Agilent, Santa
Clara, CA), and each were pooled into molar equivalents.
Resulting pools were sequenced on 314 chips using an Ion
Torrent Personal Genome Machine (PGM) according to
manufacturer’s instructions (Life Technologies, Grand Is-
land, NY) [36]. Barcoded sequences then were binned ac-
cording to 100% matching barcodes. Each read was
trimmed according to modified Phred scores of 0.5, and
low complexity reads (where >25% of the length were due
to homopolymer tracts) and reads with ambiguous charac-
ters were removed prior to further analysis using CLC
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MA). Only those reads that had 100% matching sequences
to both the 5’ and the 3’ end of the CRISPR repeat motifs
were used for further evaluation. Spacers were defined as
any nucleotide sequences (length ≥20) in between repeat
motifs. Spacers then were grouped according to their trinu-
cleotide content, as previously described [10]. Briefly, the
trinucleotide content was compiled for all spacers and
added to a database. For each spacer sequence, the differ-
ence in trinucleotide content was compared between all
possible spacer pairs. The sum of the differences for all
spacer pairs then was determined for all sequences, and
then spacers were binned together if their differences were
less than the standard deviation from the mean overall
difference.
For each subject evaluated, a database of spacer groups
was generated, and databases were compared to deter-
mine shared spacer groups and to create heatmaps using
Java Treeview [43]. Spacer heat matrices were created
using Microsoft Excel 2007 (Microsoft Corp., Redman,
WA). Beta diversity was determined using binary Soren-
sen distances, and was used as input for principal
coordinates analysis using Qiime [44]. Spacers from
each subject were subjected to BLASTN [34] analysis
based on the NCBI Non-redundant database. Hits were
considered significant based on bit scores ≥45, which
roughly correlates to 2 nucleotide differences over the
length of a 30 nucleotide spacer. The number of blast
homologues then were normalized for each subject, and
heatmaps were created using Java Treeview [43]. Spacers
also were queried against the loci present in the CRISPR
Database [38] or other specified metagenomic datasets,
and only spacers that were identical or had a single mis-
match over the entire length of the spacer were consid-
ered matches. CRISPR spacers for each subject were
used to search a database of the virome reads for
matches from all viromes combined, and the number of
spacer matches per virome read was used to create
heatmaps. The heatmaps were normalized by the total
number of spacer matches per virome read, and were
generated using Java Treeview [43]. Rarefaction analysis
was performed based on spacer group richness estimates
of 10,000 iterations using EcoSim [45]. CRISPR loci were
reassembled from reads that had a minimum of 2 full
spacer sequences flanked by full-length repeat motifs.
Each locus was reassembled based on matching adjacent
spacers, in which reads were only assembled into loci if
their adjacent spacers were present in the same combin-
ation in at least 75% of the reads assessed.
Isolation and analysis of viromes
Saliva from human subjects was filtered sequentially
through 0.45 μ and 0.2 μ filters to remove cellular debris,
and the remaining fraction purified on a cesium chloridegradient as previously described [8]. Only the fraction at
the density of most known viruses [46] was retained; it was
then further purified on Amicon YM-100 protein purifica-
tion columns (Millipore, Inc., Bellerica, MA), and treated
with DNASE I, followed by lysis and DNA purification
using Qiagen UltraSens virus kit (Qiagen, Valencia, CA).
Resulting DNA was amplified using GenomiPhi V2 MDA
amplification (GE Healthcare, Pittsburgh, PA), fragmented
to roughly 100 to 200 bp using a Bioruptor (Diagenode,
Denville, NJ), constructed into libraries using the Ion Plus
Fragment Library Kit according to manufacturer’s instruc-
tions, and sequenced using 316 chips on an Ion Torrent
PGM (Life Technologies, Grand Island, NY) [36] producing
an average read length of approximately 100 bp for each
sample. Each read was trimmed according to modified
Phred scores of 0.5 using CLC Genomics Workbench 4.65
(CLC bio USA, Cambridge, MA), and low complexity reads
(where >25% of the length were due to homopolymer
tracts) were removed prior to further analysis. Any
remaining reads with substantial length variation (<50 nu-
cleotides or >200 nucleotides) or reads with ambiguous
characters were removed from the analysis. To ensure that
the viral communities were properly separated from poten-
tial contaminating cellular elements, we screened each vir-
ome against the RDP 16S ribosomal RNA database [47]
and the RefSeq human database available at NCBI (ftp://
ftp.ncbi.nlm.nih.gov/refseq/H_sapiens/). CRISPR spacer/vir-
ome read matches were defined as virome sequences that
were identical or had a single nucleotide mismatch when
compared to the CRISPR spacer sequences.
Analysis of 16S rRNA
We amplified the bacterial 16S rRNA V3 hypervariable
region using the forward primer 341 F (CCTACGG
GAGGCAGCAG) fused with the Ion Torrent Adaptor
A sequence and one of 23 unique 10 base pair barcodes,
and reverse primer 514R (ATTACCGCGGCTGCTGG)
fused with the Ion Torrent Adaptor P1 from the skin
and salivary DNA of each subject [48]. PCR reactions
were performed using Platinum PCR SuperMix (Invitro-
gen, Carlsbad, CA) with the following cycling parame-
ters: 94°C for 10 minutes, followed by 30 cycles of
94°C for 30 seconds, 53°C for 30 seconds, 72°C for
30 seconds, and a final elongation step of 72°C for 10 mi-
nutes. Resulting amplicons were purified on a 2% agar-
ose gel stained with SYBR Safe (Invitrogen, Carlsbad,
CA) using the MinElute PCR Purification kit (Qiagen,
Valencia, CA). Amplicons were further purified with
Ampure beads (Beckman-Coulter, Brea, CA), and molar
equivalents were determined for each sample using a
Bioanalyzer 2100 HS DNA Kit (Agilent Technologies,
Santa Clara, CA). Samples were pooled into equimolar
proportions and sequenced on 314 chips using an Ion Tor-
rent PGM according to manufacturer’s instructions (Life
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reads were removed from the analysis if they were <130 nt,
had any barcode or primer errors, contained any ambigu-
ous characters, or contained any stretch of >6 homopoly-
mers. Sequences were assigned to their respective samples
based on their 10-nt barcode sequence, and were analyzed
further using the Qiime pipeline [45]. Briefly, representative
OTUs from each set were chosen at a minimum sequence
identity of 97% using UClust [49] and aligned using PyNast
[50] against the Greengenes database [51]. Multiple align-
ments then were used to create phylogenies using FastTree
[52], and taxonomy was assigned to each OTU using the
RDP classifier [53,54]. Principal coordinates analysis was
performed based on Beta Diversity using weighted Unifrac
distances [55].
Statistical analysis
To assess whether spacer groups had significant overlap
between the skin and saliva for each subject, we per-
formed a permutation test. We simulated the distribu-
tion of the fraction of shared spacer groups from 2
different time points within individual subjects that were
randomly chosen across all time points. For each set, we
computed the summed fraction of shared spacer groups
comparing randomly chosen skin spacers with randomly
chosen salivary spacers, and from these computed an
empirical null distribution of statistics. The fraction
computed in each of 10,000 iterations resulted from the
random sampling of 1000 spacer groups. The standard
deviation was computed from the percentage of shared
spacer groups over the 10,000 iterations. The simulated
statistics for the skin and saliva in each subject were
referred to the null distribution comparing skin and
salivary spacers, and the p value was computed as the
fraction of times the simulated statistic for the each
exceeded the null distribution. The same technique was
utilized for 16S rRNA OTUs and to test the proportions
of shared spacers in each subject by time of day.
To determine a relative rate at which new spacers
were identified in each subject and sample type, we
estimated the number of shared spacers between two
samples (observed at different times). A naive estimate
that simply computes the number of spacers observed at
both times or each time exclusively to estimate these
quantities does not take into account statistical variation
in spacer content due to sampling depth, or the chance
that a spacer will not be observed due to Poisson sam-
pling. To estimate this bias, n10, n01 and n11 respect-
ively denote the number of spacer groups present at the
first sampling time point and not the second, the second
but not the first, and both samples. By using the empirical
estimates of these quantities, we could correct for any un-
derestimates from using the observed numbers of spacer
groups. We therefore used a statistical model tocorrect for this bias and estimate the rate of change be-
tween spacer populations. To estimate each of these
three quantities, we used statistics s10, s01, s11 repre-
senting the observed numbers of spacer groups in each
category, but each was necessarily an underestimate of
n10, n01 and n11. p and q denote the probabilities of
seeing a spacer group if it is present at time 0 or time
1. The expectation of each can be calculated as: E(s01) =
(((1-q)*n01) + ((1-p)*(q*n11))), E(s10) = (((1-p)*n10) + ((1-
q)*(p* n11)), and E(s11) = (p*q*n11), where p = 1/N sum_i
e^{−lambda_i} for sample 1 and q = 1/N sum_i e^{−lamb-
da_i} for sample 2, where lambda_i is the depth that spacer
group i is sampled. These estimates were used to determine
the proportion of spacers shared between consecutive time
points for each subject and sample type.
Comparisons of the mean percentages of shared
spacers and standard error rates in different subjects
or between the skin and saliva of each subject
were performed using Microsoft Excel 2007 (Microsoft
Corp., Redman, WA). Statistical significance was deter-
mined by two-tail t-test for comparison of means, and
by single factor ANOVA when comparing the propor-
tions of shared spacers between SGI and SGII CRISPR
spacer types.
Availability of supporting data
All sequences are available for download in the MG-
RAST database (metagenomics.anl.gov/) under the pro-
ject ‘CRISPR Skin Saliva Project’. Virome sequences are
available under consecutive individual accession num-
bers 4513846.3 to 4513853.3, and 16S rRNA sequences
are available under consecutive individual accession
numbers 4514730.3 to 4514825.3.
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